| Synthesis, in vitro anticancer and antimycobacterial evaluation of new 5-(2, 5-dimethoxyphenyl)-1, 3, 4-thiadiazole-2-amino derivatives N Polkam, P Rayam, JS Anireddy, S Yennam, HS Anantaraju, ... Bioorganic & Medicinal Chemistry Letters 25 (7), 1398-1402, 2015 | 63 | 2015 |
| Synthesis and α-glucosidase inhibition activity of dihydroxy pyrrolidines S Kasturi, S Surarapu, S Uppalanchi, JS Anireddy, S Dwivedi, ... Bioorganic & Medicinal Chemistry Letters 27 (12), 2818-2823, 2017 | 54 | 2017 |
| Synthesis, molecular properties prediction and anticancer, antioxidant evaluation of new edaravone derivatives N Polkam, VR Ramaswamy, P Rayam, TR Allaka, HS Anantaraju, ... Bioorganic & Medicinal Chemistry Letters 26 (10), 2562-2568, 2016 | 40 | 2016 |
| Synthesis, characterization and biological evaluation of bile acid-aromatic/heteroaromatic amides linked via amino acids as anti-cancer agents DS Agarwal, HS Anantaraju, D Sriram, P Yogeeswari, SH Nanjegowda, ... Steroids 107, 87-97, 2016 | 36 | 2016 |
| Sugar-boronate ester scaffold tethered pyridyl-imine palladium (II) complexes: synthesis and their in vitro anticancer evaluation ER Reddy, R Trivedi, AVS Sarma, B Sridhar, HS Anantaraju, D Sriram, ... Dalton Transactions 44 (40), 17600-17616, 2015 | 27 | 2015 |
| Optimization and validation of Mycobacterium marinum-induced adult zebrafish model for evaluation of oral anti-tuberculosis drugs JP Sridevi, HS Anantaraju, P Kulkarni, P Yogeeswari, D Sriram The International Journal of Mycobacteriology 3 (4), 259-267, 2014 | 26 | 2014 |
| Cathepsin D inhibitors as potential therapeutics for breast cancer treatment: Molecular docking and bioevaluation against triple-negative and triple-positive breast cancers HS Anantaraju, MB Battu, S Viswanadha, D Sriram, P Yogeeswari Molecular diversity 20, 521-535, 2016 | 24 | 2016 |
| Synthesis of novel cytotoxic tetracyclic acridone derivatives and study of their molecular docking, ADMET, QSAR, bioactivity and protein binding properties R Veligeti, RB Madhu, J Anireddy, VR Pasupuleti, VKR Avula, KS Ethiraj, ... Scientific Reports 10 (1), 20720, 2020 | 22 | 2020 |
| Design and synthesis of oxaprozin‐1, 3, 4‐oxadiazole hybrids as potential anticancer and antibacterial agents P Rayam, N Polkam, N Kuntala, V Banothu, HS Anantaraju, Y Perumal, ... Journal of Heterocyclic Chemistry 57 (3), 1071-1082, 2020 | 17 | 2020 |
| Design and synthesis of 1,2,3-triazole–etodolac hybrids as potent anticancer molecules SDGBNB Bhaskar Kummari, Naveen Polkam,Perla Ramesh, Hasithashilpa Anantaraju ... RSC Advances 7, 23680-23686, 2017 | 17 | 2017 |
| Identification of potential Mycobacterium tuberculosis topoisomerase I inhibitors: A study against active, dormant and resistant tuberculosis JP Sridevi, P Suryadevara, R Janupally, J Sridhar, V Soni, HS Anantaraju, ... European Journal of Pharmaceutical Sciences 72, 81-92, 2015 | 16 | 2015 |
| Discovery of novel lysine ɛ-aminotransferase inhibitors: an intriguing potential target for latent tuberculosis PB Devi, JP Sridevi, SS Kakan, S Saxena, VU Jeankumar, V Soni, ... Tuberculosis 95 (6), 786-794, 2015 | 15 | 2015 |
| Design and Synthesis of New Etodolac‐Pyridazinones as Potent Anticancer Agents Using Pb(OAc)4 to Assist N‐N Bond Formation B Kummari, P Ramesh, R Parsharamulu, TR Allaka, H Anantaraju, ... ChemistrySelect 3 (18), 5050-5054, 2018 | 9 | 2018 |
| Synthesis of New Heteroaryl Substituted Morpholine Tagged Triazines and Evaluation of their Cytotoxic Activity S Kasturi, S Surarapu, S Uppalanchi, HS Anantaraju, S Dwivedi, ... Letters in Drug Design & Discovery 15 (2), 181-192, 2018 | 2 | 2018 |
| Optimization and validation of Mycobacterium JP Sridevi, HS Anantaraju, P Kulkarni, P Yogeeswari, D Sriram | | 2014 |
| Journal Name RSCPublishing ER Reddy, R Trivedi, AVS Sarma, B Sridhar, HS Anantharaju, D Sriram, ... | | |
